Allied (ALID) Stock Price

Allied Price

CLOSED
0.00
​
Market closed

Revenue has compounded at 112.7% per year over the past 3 years to 96,200.00 USD. Allied's net margin stands at -4,133.3%, up from -114,900.0% several years earlier.

Allied stock price

Access this data via the Eulerpool API

Allied business model & stock analysis

Allied Corp. engages in the research, creation, and production of cannabinoid health solutions. The company is headquartered in Kelowna, British Columbia. The company went IPO on 2018-12-04. The firm is focused on the development of medicinal cannabis and psilocybin products for patients with conditions potentially suitable for treatment there with. Such conditions include anxiety, insomnia, anorexia, chronic pain, epilepsy, chemotherapy-induced nausea and vomiting, post-traumatic stress disorder (PTSD), Parkinson’s disease, Tourette syndrome, irritable bowel syndrome (IBS) and spasticity associated with multiple sclerosis (MS) and spinal cord injury (SCI)1. Its wholly owned subsidiaries include AM Biosciences, Allied US Products LLC, Tactical Relief LLC, Baleno Ltd., and Allied Colombia.

Frequently asked questions about Allied

Converted at the current exchange rate, the Allied share trades at 0.00 EUR (0.00 USD).

The revenue cannot currently be calculated for Allied.

The profit cannot currently be calculated for Allied.

The P/E ratio cannot be calculated for Allied at the moment.

The P/S cannot be calculated for Allied currently.

The Eulerpool Quality Score for Allied is 4/10.

The ISIN of Allied is US0191141078. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Allied is ALID. The ticker symbol is used to trade Allied shares on the stock exchange.

Fair ValueTerminal
0.00 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
USD
Initial public offering
Dec 4, 2018
ISIN
US0191141078
Cusip
019114107
Market capitalization
57,750.00 USDMicro Cap
52-Week Range
Revenue growth (10Y) > 5%
Revenue growth (3Y) > 5 %
EBIT growth (10Y) > 5%
EBIT growth (3Y) > 5 %
Net debt < 4x EBIT
Profitable since 10Y+
EBIT Drawdown (10Y) < 50%
Return on Equity (ROE) > 15%
ROCE > 15%
Return Expectation > 10%
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.02
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
370.22 %
Gross Margin
-335.86 %
EBIT Margin
-2,951.14 %
Net Margin
-4,133.26 %
EPS (Earnings Per Share)
-0.04 USD
Net Debt / EBIT
-2.15
Debt/Equity
-0.86
Last updated Oct 2, 2026, 8:36 AM

Allied Peer Group

Allied FIGI

ALID:US · BBG000CG9TW2ALID:PQ · BBG002HS4TG0ALID:UV · BBG002HS4TJ7

All fundamentals and in-depth analysis of Allied

Our stock analysis for Allied stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Allied. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.